The family of a woman who died in hospital from Covid-19 pursued a High Court claim for damages ‘in her memory’.

The family of a 61-year-old woman who died from Covid-19 after repeated transfers between a hospital and a step-down facility has settled a High Court action over her death.

This is the first case to come before the courts in relation to a person contracting the virus during the covid pandemic ...

Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant patients.

In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte globulin (ATG), induces injury to blood vessels in the liver. According to the ...

Optimized immunosuppressive regimens support the survival of transplanted iPSC-CMs without immune rejection, advancing safer regenerative therapies for severe heart failure. While current clinical ...

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...

When the FDA reworked the prescribing information for Sarepta Therapeutics' Duchenne muscular dystrophy (DMD) gene therapy Elevidys earlier this month, the company touted a plan to study a regimen ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA ...

For first-time kidney transplant recipients older than 65 years, reducing tacrolimus dose was feasible, but it did not improve kidney transplantation success or graft function compared with use of ...